{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:48:12Z","timestamp":1767142092956,"version":"build-2238731810"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12020-020-02446-7","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T10:02:36Z","timestamp":1596967356000},"page":"208-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A mutation in NOTCH2 gene first associated with Hajdu\u2013Cheney syndrome in a Greek family: diversity in phenotype and response to treatment"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7345-7912","authenticated-orcid":false,"given":"Zoe A.","family":"Efstathiadou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charilaos","family":"Kostoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotini","family":"Adamidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,9]]},"reference":[{"key":"2446_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.metabol.2017.08.002","volume":"80","author":"E Canalis","year":"2018","unstructured":"E. Canalis, Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders. Metab. Clin. Exp. 80, 48\u201356 (2018).","journal-title":"Metab. Clin. Exp"},{"key":"2446_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-3-030-34436-8_9","volume":"1218","author":"J Reichrath","year":"2020","unstructured":"J. Reichrath, S. Reichrath, Notch Pathway and Inherited Diseases: Challenge and Promise. Adv. Exp. Med. Biol 1218, 159\u2013187 (2020).","journal-title":"Adv. Exp. Med. Biol"},{"key":"2446_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/ajmg.a.35772","volume":"161","author":"Y Narumi","year":"2013","unstructured":"Y. Narumi, B.J. Min, K. Shimizu, I. Kazukawa, K. Sameshima, K. Nakamura, T. Kosho, Y. Rhee, Y.S. Chung, O.H. Kim, Y. Fukushima, W.Y. Park, G. Nishimura, Clinical consequences in truncating mutations in exon 34 of NOTCH2: Report of six patients with Hajdu-Cheney syndrome and a patient with serpentine fibula polycystic kidney syndrome. Am. J. Med. Genet., Part A 161, 518\u2013526 (2013).","journal-title":"Am. J. Med. Genet., Part A"},{"key":"2446_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11914-016-0311-6","volume":"14","author":"E Canalis","year":"2016","unstructured":"E. Canalis, S. Zanotti, Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations. Curr. Osteoporos. Rep. 14, 126\u2013131 (2016).","journal-title":"Curr. Osteoporos. Rep."},{"key":"2446_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bone.2016.08.025","volume":"92","author":"G Adami","year":"2016","unstructured":"G. Adami, M. Rossini, D. Gatti, G. Orsolini, L. Idolazzi, O. Viapiana, A. Scarpa, E. Canalis, Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab. Bone. 92, 150\u2013156 (2016).","journal-title":"Bone."},{"key":"2446_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00198-006-0221-z","volume":"18","author":"FE McKiernan","year":"2007","unstructured":"F.E. McKiernan, Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome. Osteoporos. Int. 18, 245\u2013249 (2007).","journal-title":"Osteoporos. Int."},{"key":"2446_CR7","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1128\/MCB.00299-08","volume":"28","author":"H Fukushima","year":"2008","unstructured":"H. Fukushima, A. Nakao, F. Okamoto, M. Shin, H. Kajiya, S. Sakano, A. Bigas, E. Jimi, K. Okabe, The Association of Notch2 and NF- B Accelerates RANKL-Induced Osteoclastogenesis. Mol. Cell. Biol. 28, 6402\u20136412 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"2446_CR8","doi-asserted-by":"publisher","first-page":"14203","DOI":"10.1074\/jbc.RA119.009824","volume":"294","author":"J Yu","year":"2019","unstructured":"J. Yu, E. Canalis, The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor \u03b1. J. Biol. Chem. 294, 14203\u201314214 (2019).","journal-title":"J. Biol. Chem."},{"key":"2446_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4049\/jimmunol.1801032.","volume":"203","author":"S Jastrzebski","year":"2019","unstructured":"S. Jastrzebski, J. Kalinowski, S. Mun, B. Shin, N.S. Adapala, C.E. Jacome-Galarza, F. Mirza, H.L. Aguila, H. Drissi, A. Sanjay, E. Canalis, S.-K. Lee, J.A. Lorenzo, Protease-activated receptor 1 deletion causes enhanced osteoclastogenesis in response to inflammatory signals through a Notch2-dependent mechanism. J. Immunol. 203, 105\u2013116 (2019). https:\/\/doi.org\/10.4049\/jimmunol.1801032.","journal-title":"J. Immunol."},{"key":"2446_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm1716","volume":"14","author":"MJ Hilton","year":"2008","unstructured":"M.J. Hilton, X. Tu, X. Wu, S. Bai, H. Zhao, T. Kobayashi, H.M. Kronenberg, S.L. Teitelbaum, F.P. Ross, R. Kopan, F. Long, Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 14, 306\u2013314 (2008).","journal-title":"Nat. Med."},{"key":"2446_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MCD.0000000000000034","volume":"23","author":"M Descartes","year":"2014","unstructured":"M. Descartes, K. Rojnueangnit, L. Cole, A. Sutton, S.L. Morgan, L. Patry, M.E. Samuels, Hajdu-Cheney syndrome: Phenotypical progression with de-novo NOTCH2 mutation. Clin. Dysmorphol. 23, 88\u201394 (2014).","journal-title":"Clin. Dysmorphol."},{"key":"2446_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1359\/jbmr.2003.18.1.131","volume":"18","author":"WM Drake","year":"2003","unstructured":"W.M. Drake, M.P. Hiorns, D.L. Kendler, Hadju-Cheney syndrome: Response to therapy with bisphosphonates in two patients. J. Bone Miner. Res. 18, 131\u2013133 (2003).","journal-title":"J. Bone Miner. Res"},{"key":"2446_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3349\/ymj.2011.52.3.543","volume":"52","author":"S Hwang","year":"2011","unstructured":"S. Hwang, D.Y. Shin, S.H. Moon, E.J. Lee, S.K. Lim, O.H. Kim, Y. Rhee, Effect of Zoledronic Acid on Acro-Osteolysis and Osteoporosis in a Patient with Hajdu-Cheney Syndrome. Yonsei Med. J. 52, 543\u2013546 (2011).","journal-title":"Yonsei Med. J."},{"key":"2446_CR14","doi-asserted-by":"crossref","unstructured":"J.F.H. Pittaway, C. Harrison, Y. Rhee, M. Holder-Espinasse, A.E. Fryer, T. Cundy, W.M. Drake, M.D. Irving, Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - New data and literature review. Orphanet J. Rare Dis. 13, 47 (2018).","DOI":"10.1186\/s13023-018-0795-5"},{"key":"2446_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00198-007-0461-6","volume":"19","author":"FE McKiernan","year":"2008","unstructured":"F.E. McKiernan, Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome: 2-Year follow-up. Osteoporos. Int. 19, 379\u2013380 (2008).","journal-title":"Osteoporos. Int."},{"key":"2446_CR16","first-page":"283","volume":"37","author":"A Galli-Tsinopoulou","year":"2012","unstructured":"A. Galli-Tsinopoulou, I. Kyrgios, S. Giza, E.Z. Giannopoulou, I. Maggana, N. Laliotis, Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. Minerva Endocrinologica. 37, 283\u2013289 (2012).","journal-title":"Minerva Endocrinologica."},{"key":"2446_CR17","unstructured":"National Center for Biotechnology Information. ClinVar [VCV000451587.2] (National Center for Biotechnology Information, 2019). https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/VCV000451587.2. Accessed 7 Apr 2020."},{"key":"2446_CR18","doi-asserted-by":"crossref","unstructured":"L. Graversen, M.M. Handrup, M. Irving, H. Hove, B.R. Diness, L. Risom, D. Svaneby, M.M. Aagaard, I. Vogel, H. Gj\u00f8rup, M. Davidsen, M.B. Hellfritzsch, E. Lauridsen, P.A. Gregersen, Phenotypic presentations of Hajdu-Cheney syndrome according to age \u2013 5 distinct clinical presentations. Eur. J. Med. Genet. 63, 103650 (2020).","DOI":"10.1016\/j.ejmg.2019.04.007"},{"key":"2446_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.14712\/23362936.2019.3","volume":"119","author":"J Jire\u010dkov\u00e1","year":"2018","unstructured":"J. Jire\u010dkov\u00e1, M. Magner, L. Lambert, A. Baxov\u00e1, A. Leisk\u00e1, L. Kope\u010dkov\u00e1, L. Fajkusov\u00e1, J. Zeman, The Age Dependent Progression of Hajdu-Cheney Syndrome in Two Families. Prague Med. Rep. 119, 156\u2013164 (2018).","journal-title":"Prague Med. Rep."},{"key":"2446_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/ejhg.2011.125","volume":"20","author":"MJ Gray","year":"2012","unstructured":"M.J. Gray, C.A. Kim, D.R. Bertola, P.R. Arantes, H. Stewart, M.A. Simpson, M.D. Irving, S.P. Robertson, Serpentine fibula polycystic kidney syndrome is part of the phenotypic spectrum of Hajdu-Cheney syndrome. Eur. J. Hum. Genet. 20, 122\u2013124 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"2446_CR21","first-page":"1140","volume":"6","author":"J Chacko","year":"2018","unstructured":"J. Chacko, J. Akhter, Hajdu-Cheney Syndrome Presenting with Extensive Lung Disease with Alveolar Cholesterol Granulomas. Ann. Clin. Pathol. 6, 1140 (2018).","journal-title":"Ann. Clin. Pathol."},{"key":"2446_CR22","doi-asserted-by":"crossref","unstructured":"D. Ortiz-Masi\u00e1, J. Cos\u00edn-Roger, S. Calatayud, C. Hern\u00e1ndez, R. Al\u00f3s, J. Hinojosa, J.V. Esplugues, M.D. Barrachina, M1 macrophages activate notch signalling in epithelial cells: Relevance in Crohn\u2019s disease. J. Crohn\u2019s Colitis. 10, 582\u2013592 (2016).","DOI":"10.1093\/ecco-jcc\/jjw009"},{"key":"2446_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1210\/en.2016-1787","volume":"158","author":"E Canalis","year":"2017","unstructured":"E. Canalis, A. Sanjay, J. Yu, S. Zanotti, An antibody to Notch2 reverses the osteopenic phenotype of hajdu-cheney mutant male mice. Endocrinology. 158, 730\u2013742 (2017).","journal-title":"Endocrinology."},{"key":"2446_CR24","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1210\/jc.2017-01102","volume":"102","author":"S Sakka","year":"2017","unstructured":"S. Sakka, R.I. Gafni, J.H. Davies, B. Clarke, P. Tebben, M. Samuels, V. Saraff, K. Klaushofer, N. Fratzl-Zelman, P. Roschger, F. Rauch, W. H\u00f6gler, Bone structural characteristics and response to bisphosphonate treatment in children with hajdu-cheney syndrome. J. Clin. Endocrinol. Metab. 102, 4163\u20134172 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2446_CR25","doi-asserted-by":"crossref","unstructured":"S.Y. Lee, F. Long, Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation. J. Clin. Invest. 128, 5573\u20135586 (2018).","DOI":"10.1172\/JCI96221"},{"key":"2446_CR26","doi-asserted-by":"crossref","unstructured":"J. Tao, M.M. Jiang, L. Jiang, J.S. Salvo, H.C. Zeng, B. Dawson, T.K. Bertin, P.H. Rao, R. Chen, L.A. Donehower, F. Gannon, B.H. Lee, Notch Activation as a Driver of Osteogenic Sarcoma. Cancer Cell. 26, 390\u2013401 (2014).","DOI":"10.1016\/j.ccr.2014.07.023"}],"updated-by":[{"DOI":"10.1007\/s12020-020-02479-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000}}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02446-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02446-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02446-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T19:30:35Z","timestamp":1628451035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02446-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2446"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02446-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,9]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent has been obtained by the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Zoledronic acid had been administered in these patients off-label, at the setting of good clinical practice, since no approved treatment currently exists for HCS. Subsequently, written patients\u2019 informed consent to publish data and photographs were obtained, and ethics committee (IRB of Hippokration Hospital of Thessaloniki) approved publication before data access.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}